The Inhibitory PVRL1/PVR/TIGIT Axis in Immune Therapy for Hepatocellular Carcinoma. Peng H, Fu YX. Gastroenterology 2020;159:434-436.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Peng H, Fu YX. The Inhibitory PVRL1/PVR/TIGIT Axis in Immune Therapy for Hepatocellular Carcinoma. Gastroenterology 2020;159:434-436.
PMID: 32574623